Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the beta2 adrenergic receptor

Details for Australian Patent Application No. 2006249146 (hide)

Owner Almirall, S.A.

Inventors Castro Palomino Laria, Julio Cesar; Navarro Romero, Eloisa; Gual Roig, Silvia; Crespo Crespo, Maria Isabel; Puig Duran, Carlos

Agent Davies Collison Cave

Pub. Number AU-B-2006249146

PCT Pub. Number WO2006/122788

Priority P200501229 20.05.05 ES

Filing date 17 May 2006

Wipo publication date 23 November 2006

Acceptance publication date 17 March 2011

International Classifications

C07C 217/10 (2006.01) Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton

A61K 31/135 (2006.01) - having aromatic rings, e.g. methadone

A61K 31/415 (2006.01) - 1,2-Diazoles

A61K 31/47 (2006.01) - Quinolines

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

C07C 217/26 (2006.01) Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton

C07C 233/43 (2006.01) Carboxylic acid amides

C07C 275/32 (2006.01) Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups

C07D 215/26 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 233/74 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

Event Publications

29 November 2007 PCT application entered the National Phase

  PCT publication WO2006/122788 Priority application(s): WO2006/122788

17 December 2009 Alteration of Name

  The name of the applicant has been altered to Almirall, S.A.

17 March 2011 Application Accepted

  Published as AU-B-2006249146

14 July 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006249148-Inhalator capsules

2006249144-Improved NanobodiesTM against Tumor Necrosis Factor-alpha